The Who

---

The researchers said they were able to make an independent assessment of the study data

An influential article that found that Hydroxychloroquine increases The Risk of death in the coronavirus patient was withdrawn via the data relates to.

Three of the authors of the study said they could not vouch for its accuracy, as Surgisphere, a healthcare company behind the data, would not allow an independent review of the relevant datasets.

The findings of The Who for the suspension of its audit on the anti-malaria drug.

But leaders, including US President, Donald Trump continues to tout its use.

Surgisphere chief executive Sapan Desai, the study's fourth author, told The Guardian newspaper that he'd said the cooperation with an independent audit, but the data transfer would "violate client agreements and provisions on the confidentiality".

What the study?

research for the article, published last month in the medical journal The Lancet, involved 96,000 coronavirus patients in 671 hospitals around the world. Almost 15,000 were Hydroxychloroquine , or a related form, Chloroquine is given, either alone or with an antibiotic.

they came to the conclusion that the drug showed no benefits against coronavirus and increase The Risk of patients developing cardiac arrhythmia and die.

Mandeep Mehra, a Harvard University Professor who led the study, together with Frank Ruschitzka of the University and University Hospital , and Amit Patel of the University of Utah, said in a statement that she had tried to arrange for a third party peer review of the data, but Surgisphere had refused to cooperate.

"We sincerely apologize to you, The Editors , the journal readership, The Group added for any embarrassment or inconvenience this may have caused".

is there any evidence the drug is effective against coronavirus?

It is to treat the concern in the scientific community about the use of such drugs coronavirus.

Hydroxychloroquine is safe for the treatment of malaria, and conditions such as lupus or arthritis, but So Far no clinical studies, recommended for use against Covid-19.

results from a clinical study at the University of Minnesota have shown that Hydroxychloroquine is effective in the prevention of coronavirus.

The Who Said on 3. June it would be back to his studies after the curb last month.

Other studies in several countries, including the UK, the USA and Senegal.

In March, the U.S. Food and Drug Administration issued an "emergency use" authorization for the use of a limited number of inpatient cases. But in The Following month, it gave A Warning about its use because of reports of heart problems in some patients.

Why has it gained importance?

Despite concerns for its safety and efficacy, U.S. President Donald Trump revealed in may that He Said was taking Hydroxychloroquine as a preventive measure against Covid-19, but later, he would have stopped.

Mr Trump has repeatedly called to its potential. At a Press Conference in April, He Said : "What have you got to lose? You can take it. "

Following Mr Trump's comments, there was a sharp increase in prescriptions reported in the United States for both Hydroxychloroquine and the related drug Chloroquine .

Brazilian President Jair Bolsonaro has also been removed by Facebook for violating its misinformation guidelines.

There has also been a global increase in the demand for them.

Source of news: bbc.com